United States · FDA National Drug Code directory
Piperacillin, Tazobactam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-181_a6724256-14c5-4408-83a5-a964f146f0d5
- Product NDC
- 25021-181
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Piperacillin Sodium, Tazobactam Sodium
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210228
- Source listing expiry
- 20261231
Source-listed ingredients
- PIPERACILLIN SODIUM — 36 g/152mL
- TAZOBACTAM SODIUM — 4.5 g/152mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (25021-181-99) / 152 mL in 1 BOTTLE · 25021-181-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →